ASP3026 was identified in an ALK inhibition assay aimed at the oncogenic fusion kinase echinoderm-microtubule-associated protein-like 4-ALK (EML4-ALK) that has been detected in a subgroup of NSCLC patients [19, 20]. This evidence concerns the gene EML4 and non-small cell lung carcinoma.